Mirae Asset

Mirae Asset Global Investments is a South Korea-based asset management firm founded in 1997. The company has expanded its presence to 12 countries, including Australia, the United States, and various Asian markets. It offers a diverse range of investment solutions, including traditional equity and fixed income products, exchange-traded funds (ETFs), and alternative strategies such as hedge funds. Mirae Asset is committed to providing clients with insightful financial strategies tailored to their investment needs, emphasizing high ethical standards and a client-first approach. By adhering to fundamental investment principles and leveraging a research-driven methodology, the firm aims to identify opportunities that generate lasting value. The company actively recruits talented professionals to foster teamwork and innovation as it continues to grow globally while maintaining a commitment to the communities it serves.

Seong-ho Ahn

Head of Division

Rahul Chadha

Chief Investment Officer

Ashish Dave

Chief Executive Officer

Ryan Houlton

Head - Operations, Investment Manager

Nicolas Jones

Head of UK Sales, MD

Angela Mak

Executive Director, Global Investment Coverage

DongChul Shin

Executive Director, Head of Real Estate Investment Division 1

Past deals in Series B

ON

Series B in 2022
GameOn Inc. is a San Francisco-based company that specializes in developing a mobile application designed for sports fans. The app facilitates real-time interaction by allowing users to chat with friends while receiving updates such as news, scores, and highlights about their favorite teams. The company also offers a ChatOS platform that enhances brand engagement by connecting fans with relevant content and fostering deeper connections based on their interests. Utilizing a proprietary language model, GameOn's platform enables efficient communication between brands and consumers, supporting user retention and engagement. This innovative approach not only enhances the fan experience but also aids businesses in driving profitability and monetization through effective chat interactions.

AmazeVR

Series B in 2022
AmazeVR is a virtual concert platform that specializes in creating and distributing high-quality immersive music experiences. Founded in 2015 by former executives of Kakao, the company offers an end-to-end solution that includes advanced technologies such as ultra-high-resolution custom cameras and cloud-based creation tools. AmazeVR enables fans to attend live concerts in virtual reality, thereby enhancing the connection between artists and audiences. The platform facilitates both offline distribution through events like the Amaze Tour, which adheres to COVID-19 safety guidelines, and online distribution via the Amaze Music app and other media platforms such as YouTube, TikTok, and Twitch. By vertically integrating its distribution channels, AmazeVR aims to expand artists' reach and foster engaging social interactions among fans, who can connect as avatars in a shared virtual space.

Nextbillion.ai

Series B in 2022
Nextbillion.ai Pte. Ltd., established in 2019 and based in Singapore, focuses on developing AI-powered hyperlocal solutions, particularly in the realm of mapping. The company offers products like nextbillionmaps, which provides advanced mapping solutions, and nextbilliontasks, which integrates AI with human intelligence. Targeting markets with complex geospatial challenges such as India, Indonesia, and Nigeria, Nextbillion.ai aims to create robust geospatial infrastructure that facilitates location-based experiences for a growing user base. The company addresses issues stemming from underdeveloped infrastructure, the emergence of mega cities, complicated address systems, and dynamic road networks by leveraging a combination of data, artificial intelligence, and human input to solve these intricate problems.

Jai Kisan

Series B in 2022
Jai Kisan is a fintech platform that provides sustainable financing for rural emerging markets. They helping farmers understand their financial status through a next-generation/hyper-localized agriculture credit score digitizing their finances and farm capabilities for financial institutions. The platform also offers securitization solutions and a tech-led value proposition for the sellers of products and services it finances. It also uses a network of tech-enabled channel partner stores, while leveraging the existing vendor network to help source more customers. Jai Kisan was founded in 2017 and is headquartered in Mumbai, Maharashtra, India.

NextBillion

Series B in 2022
Exploring the connection between development and enterprise through blogs and analysis.

Rael

Series B in 2022
Rael Inc. researches, develops, and sells natural and organic feminine care products. It offers pads, liners, and tampons made from organic cotton. The company sells its product online. Rael Inc. was founded in 2017 and is headquartered in Buena Park, California.

Nextbillion.ai

Series B in 2022
Nextbillion.ai Pte. Ltd., established in 2019 and based in Singapore, focuses on developing AI-powered hyperlocal solutions, particularly in the realm of mapping. The company offers products like nextbillionmaps, which provides advanced mapping solutions, and nextbilliontasks, which integrates AI with human intelligence. Targeting markets with complex geospatial challenges such as India, Indonesia, and Nigeria, Nextbillion.ai aims to create robust geospatial infrastructure that facilitates location-based experiences for a growing user base. The company addresses issues stemming from underdeveloped infrastructure, the emergence of mega cities, complicated address systems, and dynamic road networks by leveraging a combination of data, artificial intelligence, and human input to solve these intricate problems.

Vyriad

Series B in 2022
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.

AmazeVR

Venture Round in 2022
AmazeVR is a virtual concert platform that specializes in creating and distributing high-quality immersive music experiences. Founded in 2015 by former executives of Kakao, the company offers an end-to-end solution that includes advanced technologies such as ultra-high-resolution custom cameras and cloud-based creation tools. AmazeVR enables fans to attend live concerts in virtual reality, thereby enhancing the connection between artists and audiences. The platform facilitates both offline distribution through events like the Amaze Tour, which adheres to COVID-19 safety guidelines, and online distribution via the Amaze Music app and other media platforms such as YouTube, TikTok, and Twitch. By vertically integrating its distribution channels, AmazeVR aims to expand artists' reach and foster engaging social interactions among fans, who can connect as avatars in a shared virtual space.

Vastai Technologies

Series B in 2021
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.

Spatial

Series B in 2021
Spatial Systems, Inc. is a New York-based company founded in 2016 that offers an augmented workplace platform designed to enhance collaboration and productivity. The platform enables users to conduct meetings using spatial audio and 3D telepresence, facilitating a more immersive interaction. It also allows for the sharing and organization of various digital content, such as 3D models, videos, documents, images, and websites, effectively transforming traditional work environments into dynamic digital workspaces. By leveraging cutting-edge technology, Spatial aims to empower individuals and organizations to unlock their creative potential and improve connectivity. The company has attracted investment from notable venture firms and angel investors, underscoring its innovative approach within the augmented reality and virtual reality sectors.

NAVER Z

Series B in 2021
NAVER Z Corp. provides mobile apps and creators/builders' platforms to create whatever users can imagine in the virtual space. It offers ZEPETO, a virtual platform that allows users to create what they can imagine; and ZEPETO Studio, an item-maker with custom templates that allows users to publish and reach users worldwide. The company is headquartered in Seongnam-si, South Korea.

S2W

Series B in 2021
s2w lab safe and secure world is a Big data analytics solution for cyber threat response such as dark web.

Class101

Series B in 2021
Class101 Inc. develops an online platform that offers hobby classes and materials. The company offers various online courses, such as crafting, yoga, calligraphy, drawing, and cooking. It enables users to learn a new skill or hobby from practitioners in their respective fields. The company was founded in 2015 and is based in Seoul, South Korea.

Immunitas Therapeutics

Series B in 2021
Immunitas Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing targeted therapeutics for cancer patients through innovative single cell analyses. Founded in 2019, the company utilizes a single cell sequencing platform to explore the biology of immune cells within human tumors, aiming to identify novel drug targets and key biomarkers that can improve patient selection for treatment. By emphasizing research rooted in human biology, Immunitas seeks to bridge the gap between laboratory discoveries and clinical applications, addressing longstanding challenges in oncology. The company is advancing several programs toward early human studies, leveraging expertise in antibody discovery and engineering to create effective therapies that can modulate specific cancer targets.

Jupiter

Series B in 2021
Jupiter, operated by Amica Financial Technologies Private Limited, is a digital retail bank based in Mumbai, India, focused on providing a co-created banking experience tailored specifically for millennials. Established in 2019, Jupiter offers a range of services including automated savings, loans, debit cards, and 24/7 customer support. The platform also provides users with insights into their spending habits and financial growth, enhancing their understanding of personal finance. In addition to these banking services, Jupiter engages in various consultancy activities, including legal, accounting, and market research, positioning itself as a comprehensive financial service provider.

Sonoma BioTherapeutics

Series B in 2021
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Inceptio Technology

Series B in 2021
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

IRIS.TV

Series B in 2021
IRIS.TV is a universal video intelligence platform focused on onboarding, processing, and activating video data. Our mission is to provide the world’s publishers, brands, agencies, and technology providers with a comprehensive understanding of every streaming video in order to create better consumer experiences and business outcomes. Since 2013, the leading media, data, and advertising technologies have utilized IRIS.TV’s privacy-first and neutral data infrastructure to build and scale AI/ML solutions including metadata enrichment, personalized content recommendations, analytics, and contextual advertising. For more information, visit www.iris.tv.

ImmunoMet Therapeutics

Venture Round in 2021
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.

EVOS eSports

Series B in 2020
EVOS eSports, established in 2016 and based in Jakarta, Indonesia, is a prominent eSports organization that manages competitive teams across various games, including Dota 2, League of Legends, and Arena of Valor. The company is focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. This platform is designed to support professional players and content creators by providing essential infrastructure, enabling them to establish a reputation for professionalism in competitive gaming. EVOS eSports offers comprehensive support for its teams, which includes in-game coaching, training facilities, and mental wellness care. In addition to its team management, the organization also retails merchandise such as t-shirts, bands, caps, and lanyards through its online store.

jeongyookgak

Series B in 2020
JEONGYOOKGAK CO.,LTD. retails meat and dairy products online. The company offers pork, beef, chicken, egg, milk, and rice. The company was founded in 2016 and is based in Seongnam-si, South Korea.

JW Therapeutics

Series B in 2020
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T therapy for relapsed or refractory B-cell lymphoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

StradVision

Series B in 2019
StradVision, Inc. specializes in developing perception algorithms for advanced driver assistance systems (ADAS) and autonomous vehicles. Founded in 2014 and headquartered in San Jose, California, with additional offices in South Korea, Germany, India, Japan, and China, the company offers various products including SVNet External for external vehicle perception and SVNet Internal for monitoring driver and passenger status. StradVision's technology utilizes artificial intelligence and deep learning to enhance vehicle safety features such as lane detection, object recognition, and real-time environmental analysis. The firm also provides an Auto Labeling Tool for automatic annotation of key objects and road elements. With a strong emphasis on innovation, StradVision holds over 60 patents and has more than 150 pending, positioning itself as a significant player in the automotive technology sector, particularly in the transition towards autonomous driving solutions.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Coinplug

Series B in 2019
Coinplug, Inc., founded in 2013 and based in Seongnam-si, South Korea, is a blockchain development company that specializes in a range of solutions and services leveraging blockchain technology. The company operates a cryptocurrency exchange platform known as CPDAX, along with an electronic wallet service and an online point-of-sale system. Additionally, Coinplug offers Metadium, a verification platform based on blockchain, and CP Cube, a business-to-business platform that integrates blockchain and public key infrastructure technologies. Its services include SBI Cosmoney, an international remittance solution, and CP Solution, which utilizes a blockchain platform called fidoledger. With a focus on innovation, Coinplug holds over 300 blockchain patents and is actively involved in developing solutions for identity and authentication, payment processing, and asset management.

Mathpresso, Inc.

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Arcellx

Series B in 2019
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.

Wantedlab

Series B in 2019
There are currently over 5,000 companies and hundreds of thousands of users on the Wanted platform. Since 2015, companies such as IBM, Facebook, Microsoft, Ebay, Wework, Rakuten and Tencent have been using Wanted to recruit the best talent in Asia. Founded in Korea, the company has raised over USD$20million in funding and is now expanding its presence to other major cities around the world.

Vividion Therapeutics

Series B in 2019
Vividion Therapeutics, Inc., a biotechnology company, develops therapeutics to treat major unmet medical needs using the platform for proteome-wide small molecule drug discovery. The company combines a proteome-wide small molecule screening approach and synthetic chemistry techniques. It provides small molecule selectivity and creates a path to drugging any protein. The company was incorporated in 2013 and is based in San Diego, California.

Standigm

Series B in 2019
Standigm, Inc. is a South Korea-based company founded in 2015 that specializes in applying advanced artificial intelligence technologies to the pharmaceutical industry, particularly in drug discovery. The company focuses on drug repositioning, utilizing a sophisticated AI model to predict new indications for existing drugs by analyzing molecular features related to drug responses and uses. Standigm has successfully generated numerous drug candidates targeting various conditions, including cancers, Parkinson's disease, autism, and fatty liver diseases. By leveraging its AI-driven approach, Standigm aims to deliver practical benefits such as reducing time and costs in the drug discovery process while minimizing uncertainties typically associated with the development of new therapies.

Brandi

Series B in 2019
Brandi is an online marketplace based in Seoul, South Korea, specializing in women's clothing and footwear. Founded in 2014, the company operates a fashion-based retail platform that connects manufacturers, wholesalers, and customers, facilitating a seamless shopping experience. Brandi aims to cater to young consumers by offering access to a variety of trending fashion brands at affordable prices. Through its innovative platform, the company fosters growth within the fashion ecosystem, empowering customers to make informed choices while enjoying a diverse selection of products.

Zolo

Series B in 2019
Zolo is a provider of managed co-living spaces aimed at students and young professionals seeking shared accommodation options. Founded in 2015 and headquartered in Bangalore, Karnataka, India, Zolo enhances the traditional concepts of paying guest accommodations and hostels by offering a range of living amenities, from basic to luxury. Its fully furnished rooms come with essential services such as hygienic food, daily housekeeping, internet access, and security, creating a hassle-free long-term living experience. By catering specifically to the needs of individuals relocating to new cities, Zolo provides a flexible and supportive living environment.

Immotor

Series B in 2018
Immotor is a company based in Shenzhen, China, that specializes in the development and sale of portable and personal transport systems. Founded in 2016, the company offers a range of innovative products, including the Immotor GO, a portable motorized scooter, and the Immotor Super Battery, which serves as a power management source. Additionally, Immotor provides the Immotor Cloud, a tool for remote control and fleet management of the Immotor GO. The company also focuses on intelligent battery swapping systems and offers battery-as-a-service solutions for electric motorcycles and lightweight electric vehicles. Immotor is committed to promoting cleaner energy and zero emissions through its advanced technologies and products designed for outdoor activities.

AppOnboard

Series B in 2018
AppOnboard is a Los Angeles-based software company empowering creators to build businesses without any programming experience. The company offers two no-code products: Buildbox, the largest no-code mobile game engine, and AppOnboard Studio, a mobile, interactive design studio that enables anyone to create playable ads and app prototypes.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

4D Molecular Therapeutics

Series B in 2018
4D Molecular Therapeutics is a clinical-stage gene therapy company based in Emeryville, California, that specializes in developing targeted gene therapy products using evolved adeno-associated virus vectors. The company has a diverse portfolio focusing on three main therapeutic areas: ophthalmology, cardiology, and pulmonology. Key product candidates include 4D-125, currently in a Phase I/II clinical trial for treating X-linked retinitis pigmentosa; 4D-110, in a Phase I trial for choroideremia; and 4D-310, also in a Phase I/II trial for Fabry disease. Additionally, 4D Molecular Therapeutics is developing investigational new drug candidates such as 4D-150 for wet age-related macular degeneration and 4D-710 for cystic fibrosis lung disease. The company aims to address unmet medical needs through its innovative gene therapies.

Kmong

Series B in 2018
Kmong (크몽) is a Korean online talent market that enables individuals to both sell and buy services. Its categories include design, marketing, document, business, computer, music and video, life services, and handmade. Users can post up their services with a price quote on the appropriate category, which will be seen and picked up by prospective buyers. Its mobile application is available for Android devices. Kmong was established in June 2012 in Gyeongsangnam-do, Korea.

Lunit

Series B in 2018
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

TCR2

Series B in 2018
TCR2 is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep understanding of T cell receptor biology enabled the creation of a novel first-in-class approach that is highly differentiated from CAR-T cells and from T cells engineered to express defined TCR alpha/beta chains. TCR2 was founded by Dr. Patrick Baeuerle and MPM Capital. It has scientific operations in Kendall Square, Cambridge, Massachusetts to leverage best-in-class technologies and nucleate top-tier academic laboratories around the world.

Dr.Kitchen

Series B in 2017
Kitchen Doctor engages in research and development of diet programs for diabetes. Kitchen Doctor is based in Daejeon, South Korea with an additional office in Seoul, South Korea.

Blind

Series B in 2017
Blind is a community app that connects verified professionals to facilitate discussions on important workplace topics. Founded in 2013 and based in Irvine, California, with additional offices in Seoul and San Francisco, Blind allows users to communicate anonymously in private company channels and engage openly across various industries. With a global user base of over 4.1 million professionals, the platform serves as a space for sharing advice, providing feedback, and exploring relevant career information. By promoting transparency and fostering honest dialogue, Blind aims to empower users to make informed decisions and inspire positive changes in their workplaces.

ImmunoMet Therapeutics

Series B in 2017
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.

KAHR medical

Series B in 2015
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

KAHR medical

Series B in 2015
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

SMATOOS

Series B in 2015
SMATOOS (스마투스) is a Korean edtech startup that develops educational services including BeNative, BeNative Pro, and CashEnglish. BeNative Pro, launched in 2015, is the #1 English-learning service in Asia. It is currently being used by Samsung, LG, and over 2000 other companies and universities. BeNative, available on both iOS and Android devices, was released in July 2016 as a free download. Users get access to all content for free, while also being rewarded with weekly cash prizes generated from video ads. It's time to be rewarded for learning! The summer of 2016 also saw the release of CashEnglish and CashSpanish. These apps gamify language learning by also rewarding users with cash rewards. No risks involved. Just Play, Learn, Win! SMATOOS is a portmanteau of Koreanized English words meaning to "study smarter."

RIDI

Series B in 2014
RIDI Corporation is South Korea’s leading e-reading services company, headquartered in Seoul. Eyeing remarkable success for the innovation of reading experiences, the company operates Ridibooks e-book store and provides PAPER PRO. Ridibooks provides the highest quality of reading experience through e-book viewer applications, with a wide selection of e-book contents. The service is available for Ridibooks PAPER PRO (self-developed e-ink reader), iOS, Android, Windows and Mac OS X. Ridibooks now serves more than 2.77 million users and more than 1,620,000 e-book titles until today. PAPER PRO, developed by RIDI Corporation and released in December 2017, is Korea’s first 7.8-inch e-reader. PAPER PRO’s size is optimized for reading, and features an e-ink display that resembles paper books.

Ridibooks

Series B in 2014
Ridibooks is a content portal that contains webtoons, web novels, comics, and e-books. Ridibooks produce all the fun stories in the world with original content from North America to the world .From novels to economics and business books, only verified bestsellers are collected and provided.

RacoonSoft

Series B in 2014
RacoonSoft is a group of creative minds whom craving for luxury enjoyment and fun. Their goal is to become a friend to people all over the world presenting happiness through their games. Cute and adorable looking Racoon is their friendly mascot Racooni, who is acting as a connection between game users and RacoonSoft. Come and join the Exciting play of RacoonSoft!